AR028809A1 - Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica - Google Patents
Un metodo anticonceptivo y una unidad anticonceptiva oral trifasicaInfo
- Publication number
- AR028809A1 AR028809A1 ARP990106694A ARP990106694A AR028809A1 AR 028809 A1 AR028809 A1 AR 028809A1 AR P990106694 A ARP990106694 A AR P990106694A AR P990106694 A ARP990106694 A AR P990106694A AR 028809 A1 AR028809 A1 AR 028809A1
- Authority
- AR
- Argentina
- Prior art keywords
- phase
- days
- conceptive
- estrogen
- effectively equivalent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método anticonceptivo que comprende administrar durante 21 días sucesivos a una mujer en sus anos fértiles, una combinacion de un estrogeno y un progestogeno en una dosis diaria anticonceptivamente eficaz en la cual existe una primera fase de 5-8 días en la cual la combinacion comprende un progestogeno equivalente efectivamente a aproximadamente 0,065 - 0,75 mg de noretindrona y un estrogeno equivalente efectivamente a aproximadamente 23 û 28 microng de etinil estradiol; seguido de una segunda fase de 7-11 días, donde la combinacion comprende un progestogeno equivalente efectivamente a aproximadamente de 0,25 - 1,0 mg de una noretindrona y un estrogeno equivalente efectivamente a aproximadamente a aproximadamente 23 - 28 microng de etinil estradiol; seguido por una tercera fase de 3 û-7 días donde la combinacion comprende un progestogeno equivalente efectivamente a aproximadamente 0,35 - 2,0 mg de noretindrona en combinacion con un estrogeno equivalente efectivamente a aproximadamente 23 - 28 mg de etinil estradiol; y seguido por 4 - 8 días que están libres de administracion de hormonas; con la condicion de que la dosis de progestina debería incrementarse desde la primera fase a la segunda fase hasta la tercera fase y que la dosis de estrogeno debe mantenerse constante en cada fase y una unidad anticonceptiva oral trifásica.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11339498P | 1998-12-23 | 1998-12-23 | |
| US09/328,764 US6214815B1 (en) | 1998-12-23 | 1999-06-09 | Triphasic oral contraceptive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR028809A1 true AR028809A1 (es) | 2003-05-28 |
Family
ID=22349144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990106694A AR028809A1 (es) | 1998-12-23 | 1999-12-22 | Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6214815B1 (es) |
| EP (1) | EP1140109B1 (es) |
| JP (1) | JP2002533398A (es) |
| KR (1) | KR100669165B1 (es) |
| CN (1) | CN100408040C (es) |
| AR (1) | AR028809A1 (es) |
| AT (1) | ATE318605T1 (es) |
| AU (1) | AU765153B2 (es) |
| BR (1) | BR9916579A (es) |
| CA (1) | CA2356747C (es) |
| CY (1) | CY1105276T1 (es) |
| CZ (1) | CZ302568B6 (es) |
| DE (1) | DE69930157T2 (es) |
| DK (1) | DK1140109T3 (es) |
| ES (1) | ES2259481T3 (es) |
| HU (1) | HU229251B1 (es) |
| MX (1) | MXPA01006533A (es) |
| NO (1) | NO321118B1 (es) |
| NZ (1) | NZ512404A (es) |
| PL (1) | PL196715B1 (es) |
| PT (1) | PT1140109E (es) |
| RU (1) | RU2225207C2 (es) |
| SK (1) | SK287931B6 (es) |
| TR (1) | TR200101826T2 (es) |
| WO (1) | WO2000038691A1 (es) |
| ZA (1) | ZA200106006B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| HUP9900213A1 (hu) * | 1999-02-01 | 2000-12-28 | Gábor Bogye | Gyógykompozíció(k) gesztagén tipusú hormon tartalmú gyógyszerek thromb-embóliás mellékhatásainak mérséklésére |
| US20060281723A1 (en) * | 1999-04-16 | 2006-12-14 | Kafrissen Michael E | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| ATE350041T1 (de) * | 2001-05-18 | 2007-01-15 | Pantarhei Bioscience Bv | Pharmaceutishe zusammensetzung für die hormonersatztherapie |
| EP1260225A1 (en) * | 2001-05-18 | 2002-11-27 | Pantarhei Bioscience B.V. | A pharmaceutical composition for use in hormone replacement therapy |
| DK1390042T3 (da) * | 2001-05-23 | 2008-03-31 | Pantarhei Bioscience Bv | System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse |
| EP1390041B1 (en) * | 2001-05-23 | 2009-11-25 | Pantarhei Bioscience B.V. | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception |
| EP1390043A1 (en) * | 2001-05-23 | 2004-02-25 | Pantarhei Bioscience B.V. | Means and method for hormonal contraception |
| ATE347365T1 (de) * | 2001-11-15 | 2006-12-15 | Pantarhei Bioscience Bv | Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie |
| IL162182A0 (en) | 2001-12-05 | 2005-11-20 | Barr Lab Inc | Kits containing oral contraceptives and methods utilizing the same |
| DK1511496T3 (da) * | 2002-06-11 | 2007-02-05 | Pantarhei Bioscience Bv | Fremgangsmåde til behandling eller forebyggelse af immunmedierede sygdomme og farmaceutisk præparat til anvendelse heri |
| AU2003274941A1 (en) * | 2002-06-11 | 2003-12-22 | Pantarhei Bioscience B.V. | A method of treating human skin and a skin care composition for use in such a method |
| SI1526856T1 (sl) | 2002-07-12 | 2008-04-30 | Pantarhei Bioscience Bv | Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka |
| JP2004140323A (ja) * | 2002-08-20 | 2004-05-13 | Sharp Corp | 半導体レーザ装置およびその製造方法 |
| ES2298570T3 (es) | 2002-10-23 | 2008-05-16 | Pantarhei Bioscience B.V. | Composiciones farmaceuticas que comprenden derivados de estetrol para el uso en la terapia del cancer. |
| CA2524474A1 (en) | 2003-05-02 | 2004-11-18 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| CA2532089C (en) * | 2003-07-16 | 2012-05-22 | Duramed Pharmaceuticals, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| WO2005032558A1 (en) * | 2003-10-01 | 2005-04-14 | Janssen Pharmaceutica N.V. | Extended triphasic contraceptive regimens |
| DE102004026671A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| AR051931A1 (es) * | 2004-10-07 | 2007-02-21 | Duramed Pharmaceuticals Inc | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes |
| US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
| US20070254858A1 (en) * | 2006-04-27 | 2007-11-01 | Cronk Peter J | Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects |
| US20070254025A1 (en) * | 2006-04-27 | 2007-11-01 | Cronk Peter J | Oral contraceptive and acne medication combination and treatment of acne with reduced side effects |
| CN101489563A (zh) * | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
| CN101583363B (zh) * | 2007-01-08 | 2013-08-21 | 潘塔希生物科学股份有限公司 | 治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒 |
| DE102007011486A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Arzneimittel umfassend wenigstens ein Gestagen |
| US20100178323A1 (en) | 2007-07-10 | 2010-07-15 | Agis Kydonieus | Dermal Delivery Device |
| WO2010042610A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2343979B1 (en) | 2008-10-08 | 2020-04-08 | Agile Therapeutics, Inc. | Transdermal delivery |
| CA2740002C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
| US9198920B2 (en) | 2009-03-27 | 2015-12-01 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| BR112017027688A2 (pt) | 2015-06-22 | 2018-09-04 | Lipocine Inc | Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3568828A (en) | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
| US3836651A (en) | 1972-02-22 | 1974-09-17 | Biolog Concepts Inc | Novel oral contraceptive combination |
| US3969502A (en) | 1972-04-14 | 1976-07-13 | Schering Aktiengesellschaft | Method for contraception by the administration of sequential contraceptive preparations |
| DE2310963A1 (de) | 1972-04-14 | 1974-09-05 | Schering Ag | Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten |
| US3932635A (en) | 1972-04-24 | 1976-01-13 | Syntex Corporation | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens |
| DE2365103C3 (de) | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
| US4291028A (en) | 1977-12-30 | 1981-09-22 | Nichols Vorys | Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system |
| NL8001593A (nl) | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
| US4390531A (en) | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| US4921843A (en) | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| USRE35724E (en) | 1982-04-28 | 1998-02-03 | Bio-Technology General Corp. | Contraception system and method |
| US4544554A (en) | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4530839A (en) | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4616006A (en) | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4628051A (en) | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4962098A (en) | 1987-06-15 | 1990-10-09 | Warner-Lambert Company | Graduated estrogen contraceptive |
| US5023084A (en) | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| US5276022A (en) | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| US4948593A (en) | 1989-05-15 | 1990-08-14 | Alza Corporation | Osmotic dosage form comprising an estrogen and a progestogen |
| IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| IE62665B1 (en) | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
| US5453279A (en) | 1992-04-21 | 1995-09-26 | Tbs Laboratories, Inc. | Enhancing transdermal absorption compositions; transdermal dosage form; and process |
| DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
| US5747480A (en) | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
-
1999
- 1999-06-09 US US09/328,764 patent/US6214815B1/en not_active Expired - Lifetime
- 1999-12-08 PT PT99963049T patent/PT1140109E/pt unknown
- 1999-12-08 HU HU0104680A patent/HU229251B1/hu unknown
- 1999-12-08 BR BR9916579-1A patent/BR9916579A/pt not_active Application Discontinuation
- 1999-12-08 RU RU2001117204/15A patent/RU2225207C2/ru active
- 1999-12-08 CN CNB998161578A patent/CN100408040C/zh not_active Expired - Lifetime
- 1999-12-08 KR KR1020017007809A patent/KR100669165B1/ko active IP Right Grant
- 1999-12-08 PL PL349629A patent/PL196715B1/pl unknown
- 1999-12-08 CA CA002356747A patent/CA2356747C/en not_active Expired - Fee Related
- 1999-12-08 DE DE69930157T patent/DE69930157T2/de not_active Expired - Lifetime
- 1999-12-08 WO PCT/US1999/029129 patent/WO2000038691A1/en active IP Right Grant
- 1999-12-08 ES ES99963049T patent/ES2259481T3/es not_active Expired - Lifetime
- 1999-12-08 CZ CZ20012184A patent/CZ302568B6/cs not_active IP Right Cessation
- 1999-12-08 NZ NZ512404A patent/NZ512404A/en not_active IP Right Cessation
- 1999-12-08 TR TR2001/01826T patent/TR200101826T2/xx unknown
- 1999-12-08 SK SK887-2001A patent/SK287931B6/sk not_active IP Right Cessation
- 1999-12-08 DK DK99963049T patent/DK1140109T3/da active
- 1999-12-08 EP EP99963049A patent/EP1140109B1/en not_active Expired - Lifetime
- 1999-12-08 MX MXPA01006533A patent/MXPA01006533A/es active IP Right Grant
- 1999-12-08 JP JP2000590643A patent/JP2002533398A/ja active Pending
- 1999-12-08 AT AT99963049T patent/ATE318605T1/de active
- 1999-12-08 AU AU19365/00A patent/AU765153B2/en not_active Expired
- 1999-12-22 AR ARP990106694A patent/AR028809A1/es unknown
-
2001
- 2001-02-13 US US09/782,420 patent/US20010044429A1/en not_active Abandoned
- 2001-06-22 NO NO20013144A patent/NO321118B1/no not_active IP Right Cessation
- 2001-07-20 ZA ZA200106006A patent/ZA200106006B/en unknown
-
2006
- 2006-05-17 CY CY20061100638T patent/CY1105276T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR028809A1 (es) | Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica | |
| TR200200406T2 (tr) | Kadınlara oral olmayan yollarla androjenik steroidlerin uygulanması | |
| NO982815D0 (no) | Ultralav dose orale preventiver med mindre menstrasjonsbl°dning og vedvarende virkninsfullhet | |
| DK0836506T3 (da) | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen | |
| DK365887D0 (da) | Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen | |
| NZ223989A (en) | Contraceptive compositions comprising melatonin and a progestogen or an estrogen or both | |
| TR200100234T2 (tr) | Biyojen estrojensülfamatların hormon sübstitüsyon terapisinde kullanılması. | |
| NZ333750A (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| DK0917466T3 (da) | Oralt antikonceptionsmiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |